Fellowship · Los Angeles, CA
Sponsored by Children's Hospital Los Angeles
Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis.
Gastroenterology · 2025 · 144 citations · Rohit Kohli
ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1.
Journal of Crohn's & colitis · 2025 · 102 citations · Mallory Chavannes
Exposure to per- and Polyfluoroalkyl Substances and Markers of Liver Injury: A Systematic Review and Meta-Analysis.
Environmental health perspectives · 2022 · 331 citations · Rohit Kohli
AASLD Practice Statement on the evaluation and management of metabolic dysfunction-associated steatotic liver disease in children.
Hepatology (Baltimore, Md.) · 2025 · 57 citations · Rohit Kohli
AGA Clinical Practice Update on the Role of Intestinal Ultrasound in Inflammatory Bowel Disease: Commentary.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2024 · 70 citations · Mallory Chavannes
ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 2.
Journal of Crohn's & colitis · 2025 · 44 citations ·
Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial.
The lancet. Gastroenterology & hepatology · 2022 · 154 citations · Nisreen Soufi
Metabolic dysfunction-associated steatotic liver disease (MASLD) in children with obesity: An Obesity Medicine Association (OMA) and expert joint perspective 2025.
Obesity pillars · 2025 · 37 citations · Rohit Kohli